Eugene Vayman, CRNA | |
2111 S Arlington Heights Rd, Arlington Heights, IL 60005-4105 | |
(314) 706-2715 | |
Not Available |
Full Name | Eugene Vayman |
---|---|
Gender | Male |
Speciality | Nurse Anesthetist, Certified Registered |
Location | 2111 S Arlington Heights Rd, Arlington Heights, Illinois |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1306802442 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367500000X | Nurse Anesthetist, Certified Registered | 209006528 (Illinois) | Primary |
Entity Name | Quantum Anesthesia Services Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1033546833 PECOS PAC ID: 7618100751 Enrollment ID: O20140425001247 |
News Archive
In a new study, a team of scientists explains how not all masks protect the same from COVID-19 transmission.
NeuroMetrix, Inc. announced today that it expects to meet its planned launch date for its latest product, NC-stat|DPNCheck, which is a fast, accurate, and quantitative test for the evaluation of systemic neuropathies such as diabetic peripheral neuropathy.
Failure to adequately address HIV/tuberculosis coinfection is "undermining" recent gains against HIV/AIDS, United Nations officials said at the first HIV/TB Global Leaders Forum at U.N. headquarters in New York, the New York Times reports.
Immunicum, which is developing cancer vaccines, has received approval from the Swedish Medical Products Agency to start its first clinical trial. The study will be conducted on kidney cancer patients at the University Hospital in Uppsala. At the same time, the company secures substantial financing to complete the clinical trial.
Semafore Pharmaceuticals today reported encouraging data from a Phase I dose-escalation trial of SF1126 in patients with relapsed and refractory myeloma. SF1126 is a novel small molecule inhibitor of phosphoinositide-3-kinase (PI3K) and mammalian target of rapamycin (mTOR), two key members of the PI3K signaling pathway that is vital to several essential biological processes, such as cell proliferation and survival. PI3K is commonly altered in human cancers, making inhibition of the target attractive for cancer therapy.
› Verified 4 days ago
Entity Name | Northstar Anesthesia Of Illinois, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1962822395 PECOS PAC ID: 4688893878 Enrollment ID: O20140922000405 |
News Archive
In a new study, a team of scientists explains how not all masks protect the same from COVID-19 transmission.
NeuroMetrix, Inc. announced today that it expects to meet its planned launch date for its latest product, NC-stat|DPNCheck, which is a fast, accurate, and quantitative test for the evaluation of systemic neuropathies such as diabetic peripheral neuropathy.
Failure to adequately address HIV/tuberculosis coinfection is "undermining" recent gains against HIV/AIDS, United Nations officials said at the first HIV/TB Global Leaders Forum at U.N. headquarters in New York, the New York Times reports.
Immunicum, which is developing cancer vaccines, has received approval from the Swedish Medical Products Agency to start its first clinical trial. The study will be conducted on kidney cancer patients at the University Hospital in Uppsala. At the same time, the company secures substantial financing to complete the clinical trial.
Semafore Pharmaceuticals today reported encouraging data from a Phase I dose-escalation trial of SF1126 in patients with relapsed and refractory myeloma. SF1126 is a novel small molecule inhibitor of phosphoinositide-3-kinase (PI3K) and mammalian target of rapamycin (mTOR), two key members of the PI3K signaling pathway that is vital to several essential biological processes, such as cell proliferation and survival. PI3K is commonly altered in human cancers, making inhibition of the target attractive for cancer therapy.
› Verified 4 days ago
Entity Name | Ear Nose And Throat Family Clinic Of Wisconsin Sc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1578650164 PECOS PAC ID: 7911997655 Enrollment ID: O20210309001035 |
News Archive
In a new study, a team of scientists explains how not all masks protect the same from COVID-19 transmission.
NeuroMetrix, Inc. announced today that it expects to meet its planned launch date for its latest product, NC-stat|DPNCheck, which is a fast, accurate, and quantitative test for the evaluation of systemic neuropathies such as diabetic peripheral neuropathy.
Failure to adequately address HIV/tuberculosis coinfection is "undermining" recent gains against HIV/AIDS, United Nations officials said at the first HIV/TB Global Leaders Forum at U.N. headquarters in New York, the New York Times reports.
Immunicum, which is developing cancer vaccines, has received approval from the Swedish Medical Products Agency to start its first clinical trial. The study will be conducted on kidney cancer patients at the University Hospital in Uppsala. At the same time, the company secures substantial financing to complete the clinical trial.
Semafore Pharmaceuticals today reported encouraging data from a Phase I dose-escalation trial of SF1126 in patients with relapsed and refractory myeloma. SF1126 is a novel small molecule inhibitor of phosphoinositide-3-kinase (PI3K) and mammalian target of rapamycin (mTOR), two key members of the PI3K signaling pathway that is vital to several essential biological processes, such as cell proliferation and survival. PI3K is commonly altered in human cancers, making inhibition of the target attractive for cancer therapy.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Eugene Vayman, CRNA 2111 S Arlington Heights Rd, Arlington Heights, IL 60005-4105 Ph: (314) 706-2715 | Eugene Vayman, CRNA 2111 S Arlington Heights Rd, Arlington Heights, IL 60005-4105 Ph: (314) 706-2715 |
News Archive
In a new study, a team of scientists explains how not all masks protect the same from COVID-19 transmission.
NeuroMetrix, Inc. announced today that it expects to meet its planned launch date for its latest product, NC-stat|DPNCheck, which is a fast, accurate, and quantitative test for the evaluation of systemic neuropathies such as diabetic peripheral neuropathy.
Failure to adequately address HIV/tuberculosis coinfection is "undermining" recent gains against HIV/AIDS, United Nations officials said at the first HIV/TB Global Leaders Forum at U.N. headquarters in New York, the New York Times reports.
Immunicum, which is developing cancer vaccines, has received approval from the Swedish Medical Products Agency to start its first clinical trial. The study will be conducted on kidney cancer patients at the University Hospital in Uppsala. At the same time, the company secures substantial financing to complete the clinical trial.
Semafore Pharmaceuticals today reported encouraging data from a Phase I dose-escalation trial of SF1126 in patients with relapsed and refractory myeloma. SF1126 is a novel small molecule inhibitor of phosphoinositide-3-kinase (PI3K) and mammalian target of rapamycin (mTOR), two key members of the PI3K signaling pathway that is vital to several essential biological processes, such as cell proliferation and survival. PI3K is commonly altered in human cancers, making inhibition of the target attractive for cancer therapy.
› Verified 4 days ago
Ms. Jill M Thomas, APN, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 126 E. Wing St, Arlington Heights, IL 60004 Phone: 847-368-0767 Fax: 847-670-3483 | |
Doris K. Walsh, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 126 E Wing St, #182, Arlington Heights, IL 60004 Phone: 866-839-7136 Fax: 866-245-7239 | |
Jamie T Kedzior, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 800 W Central Rd, Arlington Heights, IL 60005 Phone: 847-570-2760 | |
Kenneth J. Strickland, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 126 E Wing St, #182, Arlington Heights, IL 60004 Phone: 866-839-7136 Fax: 866-245-7239 |